| Date | Title | Description | Source |
| 01.03.2024 | A wave of success for LimmaTech |
LimmaTech is a clinical stage biotech company that has built a robust pipeline of innovative vaccin... | startuptic... |
| 24.10.2022 |
Day Zero Diagnostics raises $8.2M from CARB-X | Day Zero Diagnostics announced that it received an $8.2 million award in optional stage funding from... | massdevice... |
| 15.07.2022 | As Big Pharma loses interest in new antibiotics, infe... | Forget Covid-19, monkeypox, and other viruses for the moment and consider another threat t... | endpts.com... |
| 20.04.2022 | SNIPR BIOME Initiates First-in-Human Clinical Trial with SNI... | SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001
Wed, Apr 20, 2022 07:00 CET Report... | news.cisio... |
| 25.01.2022 | SNIPR BIOME Announces U.S Food and Drug Administration grant... | SNIPR BIOME Announces U.S Food and Drug Administration grants Fast Track Designation for SNIPR001 fo... | news.cisio... |
| 11.01.2022 | SNIPR BIOME Announces FDA Clearance of Investigational New D... | SNIPR BIOME Announces FDA Clearance of Investigational New Drug (IND) Application for SNIPR001, a No... | news.cisio... |
| 19.10.2021 | CARB-X Funds the 3rd Round of Debiopharm's Targeted Antibiot... | LAUSANNE, Switzerland and BOSTON, Oct. 19, 2021 /PRNewswire/ -- Debiopharm (www.debiopharm.com), a S... | en.prnasia... |
| 11.08.2021 | Seattle startup Lumen Bioscience is working with Google to m... | Caitlin Gamble, head of informatics at Lumen Bioscience. (Lumen Photo)
Can machine learning help spu... | geekwire.c... |
| 05.08.2021 | Vaxcyte : Announces Expanded CARB-X Award to Advance Develop... | -- Award Commits an Additional $3.2 Million in Funding; Total Potential Funding of $29.7 Million Bas... | marketscre... |
| 15.07.2021 | Seattle startup Lumen Bioscience to build algae manufacturin... | Former bakery and future algae manufacturing site. (GeekWire Photo / Charlotte Schubert)
Seattle-bas... | geekwire.c... |
| 15.07.2021 | Seattle startup Lumen Biosciences to build algae manufacturi... | Former bakery and future algae manufacturing site. (GeekWire Photo / Charlotte Schubert)
Seattle-bas... | geekwire.c... |
| 09.06.2021 | ACCELERATE DIAGNOSTICS, INC.
Accelerate Diagnostics : Recei... | Accelerate Diagnostics Receives CARB-X Award to Develop Rapid Optical Imaging Technology for Sepsis ... | marketscre... |
| 01.06.2021 | BioVersys secures additional funding | | startuptic... |
| 01.06.2021 | BioVersys secures additional funding | BioVersys AG is a multi-asset Swiss pharmaceutical company focusing on developing small molecules fo... | startuptic... |
| 01.06.2021 | BioVersys gets up to USD 15.34 million CARB-X grant to furth... | BioVersys AG, a privately owned clinical-stage, multi-asset Swiss pharmaceutical company focusing on... | venturekic... |
| 01.06.2021 | BioVersys gets up to USD 15.34 million CARB-X grant to furth... | BioVersys gets up to USD 15.34 million CARB-X grant to further develop pyrrolocytosines, a novel cla... | venturelab... |
| 18.05.2021 | SUMMIT THERAPEUTICS INC.
Summit Therapeutics Announces Prec... | Cambridge, MA, May 18, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) announced today that it has se... | marketscre... |
| 03.02.2021 | Mutabilis receives CARB-X grant for 'nightmare bacteri... | On a mission to subdue the rising global threat of antibiotic resistance, the CARB-X initi... | endpts.com... |
| 11.01.2021 | Can we warp-speed antibiotic development? | Now, advocates, industry leaders and legislators have come to a consensus about the scope and urgenc... | medcitynew... |
| 14.10.2020 | CARB-X is funding Polyphor to develop a new antibiotic | This is the second antibiotic program under development by Polyphor to win funding and support from ... | startuptic... |
| 14.10.2020 | CARB-X is funding Polyphor to develop a new antibiotic | | startuptic... |
| 04.08.2020 | Could Drug-Resistant Bacteria Cause The Next Pandemic? | Venetians dressed as plague doctors pose during Carnival in their city's Piazza San Marco on ... [+]... | forbes.com... |
| 17.06.2020 | Module Innovations receives funding worth $702,000 from CARB... | The funds will be used to develop tests to diagnose UTI and identify superbugs causing the infection... | thehindubu... |
| 23.04.2020 | Bugworks Raises $7.5 Million | Bugworks Research Inc, a global biopharma start-up designing novel broad-spectrum antibiotics, annou... | citybizlis... |
| 01.04.2020 | VC funding update: 60 startups raised over $1.5B in March | Boston startups ended the first quarter of 2020 with a bang. The disruption caused by COVID-19, the ... | bizjournal... |
| 04.02.2020 | Austin Biotech Startup Looks to Double Its Team After Raisin... | Everyone knows the saying "time is money." But in hospitals time is worth even more.
Austi... | bizjournal... |
| 02.01.2020 | French biotech startup Antabio receives $4.4 million from CA... | Antabion, a Labege, France-based biotech startup announced today it has been awarded up to $4.4 mill... | techstartu... |
| 29.10.2019 | BioVersys obtains new funds for its fight against drug-resis... | | startuptic... |
| 29.10.2019 | Dupixent cleared for chronic rhinosinusitis in EU; FDA... | → Regeneron and Sanofi‘s Dupixent — a king in the eczema therapy sector — has cinched its thir... | endpts.com... |
| 19.06.2019 | Oxford Drug Design receives over £8m in grant and equity inv... | Oxford Drug Design (ODD) wins major funding awards from CARB-X, the UK Department of Health and Soci... | cambridgen... |
| 19.06.2019 | Oxford Drug Design receives over £8m in grant and equity inv... | Oxford Drug Design receives over £8m in grant and equity investment
19-06-2019
Oxford Drug Design (O... | cambridgen... |
| 17.04.2019 | Medicare payment rules hinder the fight against superbugs | Late last year, a retirement community in Vermont was quarantined after an outbreak of antibiotic re... | statnews.c... |
| 04.03.2019 | ContraFect Announces $6.94M In Funding From CARB-X | YONKERS, N.Y., March 04, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-s... | citybizlis... |
| 17.01.2019 | ContraFect Announces Additional $2.3M In Funding From CARB-X | YONKERS, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-st... | citybizlis... |
| 10.12.2018 | What’s holding pharma back from the next antibiotic breakthr... | In the five years since the alarm sounded about so-called superbugs, the world has continued to grap... | statnews.c... |
| 25.09.2018 | Researchers point to R&D treaty to spur new infectiou... | As current incentives to promote the development of new infectious disease treatments hav... | endpts.com... |
| 19.07.2018 | Pharmaceutical companies are backing away from a growing thr... | CDC
A researcher tests bacteria's ability to growth in the presence of antibiotics.
Advertisement
No... | businessin... |
| 07.05.2018 | Allergan aesthetics chief David Moatazedi becomes CEO ... | David Moatazedi
→ Allergan aesthetics chief David Moatazedi is leaving to take the helm of Ev... | endpts.com... |
| 11.04.2018 | Innovative ways to pay for new antibiotics will help fight s... | Antibiotics are the most important drug class in human history. Without them, minor infections like ... | statnews.c... |
| 31.03.2017 | A new antibiotic initiative gets its first major round of fu... | A budding transatlantic initiative devoted to developing new antibiotics is investing up to $48 mill... | statnews.c... |
| 31.03.2017 | Promentis raises $26M for glutamatergic drug R&D; ... | → Milwaukee-based Promentis Pharmaceuticals has raised $26 million in a C round. OrbiMed, ... | endpts.com... |
| - | Can we warp-speed antibiotic development? | While doctors scramble to understand the viral illness Covid-19, bacteria pose no small threat, espe... | medcitynew... |